Ad is loading...
QBNAX
Price
$37.40
Change
-$0.37 (-0.98%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

QBNAX vs VISVX

Header iconQBNAX vs VISVX Comparison
Open Charts QBNAX vs VISVXBanner chart's image
Pear Tree Polaris Small Cap Instl
Price$37.40
Change-$0.37 (-0.98%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
QBNAX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QBNAX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QBNAX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. QBNAX (4.22B). VISVX pays higher dividends than QBNAX: VISVX (1.90) vs QBNAX (0.89). QBNAX was incepted earlier than VISVX: QBNAX (32 years) vs VISVX (27 years). QBNAX is a more actively managed with annual turnover of: 30.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than QBNAX: VISVX (3000) vs QBNAX (1000000). VISVX (28.71) and QBNAX (28.61) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. QBNAX (27.33).
QBNAXVISVXQBNAX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years27 years-
Gain YTD15.71815.433102%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets4.22B57.6B7%
Annual Yield % from dividends0.891.9047%
Returns for 1 year28.6128.71100%
Returns for 3 years6.1213.2346%
Returns for 5 years27.3357.3248%
Returns for 10 years33.06108.2131%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics